ABSTRACT. Herein we report age differences of in vivo of the newborn were reported following maternal ingestion of a constriction of the fetal ductus arteriosus by nonsteroidal NSAID (lo), and nothing is known about ductal reactivity in antiinflammatory drugs in near-term and preterm rats. Two midtrimester to NSAIDs, which inhibit cyclooxygenase and depotent nonsteroidal antiinflammatory drugs, indomethacin creases endogenous prostaglandins. However. in rats, ductal conand flurbiprofen, were studied in preterm (19th and 20th striction by aspirin and indomethacin occurs only in near-term day) and near-term (21st day) rats, whose gestational fetuses, and it is weak in preterm fetuses (7. 14). Very little is period was 21.5 days. The time course of fetal ductus known about this age-related reactivity of the fetal ductus in rats constriction was studied on the 20th (preterm fetus) and and nothing is known about its mechanism despite possible the 2Ist (near-term fetus) days of gestation with indometh-clinical importance. This prompted us to study further the conacin (1 mg/kg, 10 mg/kg) and flurbiprofen (10 mg/kg). In striction of fetal DA following administration of NSAIDs to addition, 5 mg/kg of indomethacin was used on the 21st near-term and preterm pregnant rats. day. Maximal ductal constriction was noticed 8 h after
administration. Constriction of the ductus was significantly weaker on the 20th day than on the 21st day in all three MATERIALS AND METHODS studies including indomethacin 1 mglkg, 10 mg/kg, and Virgin Wistar rats (pregnancy period 2 1.5 days) were mated flurbi~rofen, 10 mg/kg. Dose-response curves were studied overnight from 1700 to 0900 h, and the presence of sperm on at administration of indomethacin On the vaginal smears dated the zero day of pregnancy. These rats were 19th, 20th* and 21st days, and flurbiprofen on the 20th fed commercial solid food and water. Drugs were administered and 21st days. With both drugs, the ductus constricted through an or-gastric tube in a suspension with 2 ml water On the 21st day than On the 20th Or 19th containing 5% arabic gum at 0900 h on the 19th, 20th. or 21st day. These studies showed a weaker constrictive response day of pregnancy. of the ductus to nonsteroidal antiinflammatory drugs in the ~~t~l DA was studied using the rapid whole-body freezing preterm fetus than in the near-term fetus. Twenty-four technique, as reported previously (14-17). Briefly. the rat was after administration of indomethacin on the 20th day, the sacrificed by cervical dislocation, and fetuses were delivered fetal ductus was dilated, although its plasma indomethacin quickly by cesarean section, and frozen quickly by immersion in concentration was high and comparable with that obtained acetone cooled to -800 c by dry ice. ~h~ frozen fetuses of each 4 after administration. These results show that the litter were weighed to obtain the mean body weight. The frozen response of the fetal ductus to indomethacin decreased thorax was trimmed and sectioned at a frontal plane on a freezing further a t 24 h after administration to preterm rats. (Pe-microtome, and the inner diameters of the pulmonary trunk and diatr Res 22567-572, 1987) DA were measured under a stereoscopic microscope and micrometer, as reported previously (14-17). The ratio of the inner Abbreviations diameter of the DA at its narrowest point to the pulmonary trunk (DA/PA) was used to evaluate the constrictive effects of DA, ductus arteriosus the drugs. NSAID, nonsteroidal antiinflammatory drug Maternal and fetal blood were collected at the time of sacrifice PA, pulmonary artery for measurement of indomethacin concentrations. Maternal blood was drawn by cardiac puncture after cesarean section with a syringe containing 0.1 ml (100 U) of heparin. Fetuses from each litter were divided into two groups, one for rapid wholeDuring the last decade, evidence has been accumulated show-body freezing and the other for blood collection. Fetal blood Was ing that the fetal DA remains patent due to endogenous prosta-collected using heparin-coated funnels by a deep cut in the neck. glandins (1-1 1) . This has been proved in lambs (1-6), rats (7, 8) , It was collected from six to eight fetuses from the same litter and rabbits (8), and humans (9-1 1). In lambs, the mechanism works studied as one sample. Blood samples were kept at 4" C for one in midterm as well as in late-term fetuses (12, 13). In humans, night before separation of plasma by centrifugation. Plasma only a few pre-term cases of persistent pulmonary hypertension samples were stored at -20" C until measurement of indomethacin by gas-liquid chromatography ( 1 8).
Reccived October biprofen was studied in addition as another potent cyclooxygen-567 568 MOMMA AND TAKAO ase inhibitor. Constriction of the fetal ductus by these NSAIDs was studied on the 19th, 20th, and 21st days with several doses (i.e. 0.01, 0.1, 1, 10, or 100 mg/kg) by sacrificing the animal at 4 h after administration, as in an earlier study (14), and doseresponse curves were compared. Because an earlier study revealed that the morphology and degree of constriction of the fetal DA changed characteristically with 24 h following administration of indomethacin (17) , reactivity of DA to the drug on different gestational days was studied at I, 4, 8, and 24 h after administration as in that study, using a moderate dose (I mg/kg) of indomethacin and a high dose (10 mg/kg) of indomethacin and flurbiprofen. The high dose was studied because our preliminary study showed a loss of constricting effect at 24 h after administration of this dose in preterm fetuses despite persistent high plasma concentrations, and because this high dose was used in earlier studies (7, 17) . In addition, reaction to 5 mg/kg indomethacin was studied on the 21st day to eliminate the possible effect of lower plasma indomethacin levels in preterm fetuses following administration of 10 mg/kg indomethacin.
In experiment 1, time courses of the fetal DA constriction and plasma indomethacin concentrations were studied following administration of 10 mg/kg indomethacin to the dams. Five to 10 dams were studied at 1, 4, 8, or 24 h after administration on the 19th, 20th, and 2 1 st day of gestation.
In experiment 2, the time course of the fetal DA constriction and plasma indomethacin concentrations were studied following administration of 5 mg/kg indomethacin to the dam on the 2 1st day of gestation. Four to five dams were studied at 1, 4, 8, or 24 h after administration.
In experiment 3, time courses of the fetal DA constriction and plasma indomethacin concentrations were studied following administration of 1 mg/kg indomethacin to the dams. Five to 10 dams were studied at 1, 4, 8, or 24 h after administration on the 20th or 2 1 st day of gestation.
In experiment 4, the relation of doses to constriction of the fetal DA was studied 4 h after administration of indomethacin.
Two to 10 dams were studied after administration of either 0.01, 0.1, 1, 10, or 100 mg/kg indomethacin on the 19th, 20th, or 2 1st days of gestation.
In experiment 5, the time course of the fetal DA constriction was studied following administration of 10 mg/kg flurbiprofen to dams. Two or three dams were studied at I, 4, 8, or 24 h after administration on the 20th or 2 1st day of gestation.
In experiment 6, the relation of doses to constriction of the fetal DA was studied 4 h after administration of flurbiprofen. Two or three dams were studied after administration of either 0.0 1,O. 1, I, 10, or 100 mg/kg flurbiprofen on either 20th or 2 1 st days of gestation. As controls, fetal DA from three dams was studied on the 19th, 20th, and 21st days of gestation without drug administration.
The results are expressed as means + SEM. Two-and 3-way analysis of variance were used and the statistical significance of differences between group means was determined by the modified t statistics (19) . The difference was considered to be significant if the p value was less than 0.05. Age effects were notable in the time-course studies. As shown in Figure 2 , 10 mg/kg indomethacin constricted the fetal ductus of the 21st day severely and persistently from 1 through 24 h after administration. However, ductal constriction by the same dosage was significantly weaker and shorter in preterm fetuses. Statistical analysis revealed that compared with the ductal constriction on the 2 1 st day the ductal constriction on the 19th and 20th day was significantly weaker at 1, 4, 8, and 24 h after administration. As shown in Figure 3 , fetal plasma concentra- tions of indomethacin were lower at 4 and 8 h in preterm rats compared with near-term rats, following administration of 10 mg/kg indomethacin, but were not less than those following administration of 5 mg/kg indomethacin on the 21st day. Because administration of 5 mg/kg indomethacin on the 2 1 st day constricted the fetal ductus severely and persistently, decreased reactivity of the preterm fetal ductus was not due to lower plasma concentrations of indomethacin. At 24 h after administration. plasma indomethacin concentrations were at high levels in both near-term and preterm fetuses in spite of the fact that the ductus was dilated fully in the preterm rats at this time.
The same age-effects were observed in other experiments. As shown in Figure 4 , administration of 1 mg/kg indomethacin constricted the fetal ductus more severely in near-term rats than in preterm rats. Plasma concentrations of indomethacin were about 1/10 of those following administration of 10 mg/kg indomethacin as shown in Figure 5 . The same age-effects were also observed with another NSAID, flurbiprofen. As shown in Figure  6 , ductal constriction following administration of 10 mg/kg flurbiprofen was severe and persistent on the 2 1st day, but it was much weaker and shorter on the 20th day.
The age effects are clearly shown in dose-response curves in Figures 7 and 8 . As shown in Figure 7 , on the 2 1st day the doseresponse curves 4 h after administration of indomethacin show more constriction of the ductus as the dose increases. However, on the 19th or 20th day, the ductal constriction was slight even with a large dose, and the differences between the values of the 21st day and those of the 19th or 20th day were significant statistically at doses of 1, 10, and I00 mg/kg. Approximately the same results were obtained with flurbiprofen. As was shown in 
DISCUSSION
The sensitivity of premature fetal DA to indomethacin or other NSAIDs is controversial, and completely different results have been reported both clinically and experimentally. In an in vitro experiment with ductal strips of fetal lamb, preterm DA constricted more than near-term DA in response to indomethacin (13) or to ibuprofen (12) in a high oxygen environment. However, in intrauterine fetal lambs in vivo and in a low oxygen environment, preterm and near-term fetuses were equally sensitive to indomethacin (6). Sharpe et al. (8) studied preterm and term rat fetuses following administration of indomethacin to the dam. They noticed the most prominent constriction of the fetal DA on the 22nd day of gestation, only modest constriction on the 20th day, and no constriction on the 18th day. The present study confirmed their results with additional data of dose-response curves and plasma indomethacin concentrations. The present study with flurbiprofen, another potent inhibitor of cyclooxygenase, provides additional evidence that the DA in the preterm fetal rat is less sensitive to inhibition of cyclooxygenase than the DA in the near-term fetal rat. This is in sharp contrast to the results of the in vitro fetal lamb experiments, but because of the different experimental methods, we cannot conclude that the different results were due to species difference.
The reason is not clear why the fetal ductus is more refractory to cyclooxygenase inhibitors in the preterm rat. Possibly the ductus is more immature structurally or metabolically in the preterm fetal rat, but these possibilities remain to be studied.
Clinically, cases with fetal ductal constriction and neonatal persistent pulmonary hypertension were reported both in preterm infants of 30 wk gestation (10) and in a full-term infant (9). Since the introduction of indomethacin therapy for patent ductus arteriosus in premature infants (20, 21) , factors related to the failure of indomethacin to close the patent ductus have been analyzed. There is some evidence showing that infants with a very low birth weight showed only a transient response to indomethacin, or none at all (22, 23) . The oxygen environment of the ductus tissue in these infants is much higher than in fetal DA. Although this difference of oxygen environment may have some modifying effect on the sensitivity of the ductus to indomethacin, the results of this experiment in fetal rats accord well with the clinical observations in that preterm fetal DA is less sensitive to indomethacin than near-term fetal DA.
The present study showed that fetal DA was dilated despite a high plasma indomethacin concentration at 24 h following administration on the 20th day of gestation. The reason for this paradoxical phenomenon is not clear. An earlier study on fetal rats showed that the DA-constricting effects of glucocorticoids were more potent on premature fetuses than on mature ones (1 6). Glucocorticoids inhibit phospholipase A2, thereby inhibiting release of arachidonic acid (24) , while NSAIDs inhibit cyclooxygenase. Arachidonic acid can be transformed by lipoxygenase into leukotrienes in addition to transformation into prostaglandins and thromboxanes by cyclooxygenase (25) . The different effects of NSAIDs and glucocorticoids are compatible with the hypothesis that leukotrienes or other related substances work to dilate DA in preterm rats. According to this hypothesis, the dilatation of DA at 24 h after administration of 10 mg/kg inhibition of cyclooxygenase, accumulation of arachidonic acid, and its transformation into DA-dilating substances, which could be leukotrienes. However, work on the near-term fetal lamb be leukotrienes. However, work on the near-term fetal lamb indicates that leukotrienes have no role in the control of ductal tonc (26) , and our hypothesis including production of DAdilating substances other than prostaglandins in the preterm fetal DA remains speculative.
The clinical significance of this paradoxical effect of a high concentration of indomethacin to preterm fetal ductus is speculative. This effect appears with high doses such as 10 mg/kg of indomethacin, and probably is also present with the usual clinical dose. This effect could cancel the constrictive effect of indomethacin to the patent ductus of preterm infants. On the other hand, this effect could open the fetal ductus when indomethacin is administered repeatedly to preterm pregnant women.
Extrapolation from fetal rats to human fetuses is not easy because the gestational period of the rat is only 2 1 or 22 days. In rats, morphogenesis of the heart is completed on the 14th day of gestation (27) , and the fetal heart grows in the last 7 or 8 days.
The human fetus spends 8 months after completion of its cardiac morphogenesis to birth. Therefore, 1 day in the fetal rat may correspond to 1 month in the human fetus. This simple comparison seems correct when considering the relative gain of the fetal body weight. In rats, fetal weight doubles in the last 2 days from the 19th day to the 21st day, while human fetal weight doubles in the last 2 months. If the results of this study are extrapolated to the human fetus at a rate of 1 day to 1 month in the gestational period, the DA of a preterm baby of 7 or 8 months of gestation is presumed to be less sensitive to a NSAID such as indomethacin than the DA of near-term fetuses. Apparently more clinical and experimental studies are needed to confirm this phenomenon.
The present study showed the time course of maternal and fetal plasma concentrations of indomethacin following oral administration of a single dose. A species' difference exists in the pharmacokinetics of indomethacin; its biological half-time is unusually long in rats (28) . No data are available on the phar- (4) macokinetics of indomethacin in the human fetus following its administration to the mother. Therefore the time course of plasma indomethacin concentration in near-term and preterm rat fetuses in this study may serve as an animal model of this problem. than that of full-term fetuses in this species. In addition, loss of the constrictive effect of a high dose of indomethacin in the preterm fetal ductus, at 24 h after administration, was noticed.
